个人简介
杰玛·罗西医生是意大利圣拉斐尔医院(IRCCS Ospedale San Raffaele)胆胰内镜与超声内镜科的胃肠病学专家,该科由保罗·乔治·阿尔奇迪亚科诺教授领导。
她于2011年毕业于米兰圣拉斐尔生命与健康大学医学与外科学专业,并于2017年在同校完成了胃肠病学专业培训。
罗西医生是胃肠病学和胆胰疾病领域的临床内镜与门诊操作顾问。她进行胃肠道诊断性检查和超声内镜(EUS)检查,尤其擅长胆胰系统检查,也包括食管、胃、十二指肠和直肠,以及细针穿刺活检(FNA)。
她还提供一般及高阶胃肠病学门诊服务,尤其专注于急慢性胰腺炎和胰腺囊性病变的临床管理。
她的研究聚焦于胆胰系统疾病,特别是胰腺囊实性病变,诊断与治疗性超声内镜,以及通过EUS引导下的**射频消融(RFA)**技术。
她是多篇国内外科研论文的作者与合著者,并积极参与国内外专业学术会议。
出版物
最新出版物
Staging esophageal cancer: low EUS accuracy in t2n0 patients
Endosc Int Open. 2021 Mar;9(3):E313-E318. doi: 10.1055/a-1336-2505. Epub 2021 Feb 18. PMID: 33655027; PMCID: PMC7892275.
A narrative review of the role of endoscopic ultrasound (EUS) in lung cancer staging
Mediastinum. 2021 Mar 25;5:1. doi: 10.21037/med-20-51. PMID: 35118307; PMCID: PMC8794446.
EUS-guided gastroenterostomy in a COVID-19-infected patient with duodenal stenosing lymphoma (with videos)
Endosc Ultrasound. 2021 May-Jun;10(3):221-223. doi: 10.4103/EUS-D-20-00255. PMID: 33885002; PMCID: PMC8248301.
Exploring chemotherapy holiday and drugs re-challenge in advanced pancreatic cancer patients
Cancer Chemother Pharmacol. 2021 Jan;87(1):95-101. doi: 10.1007/s00280-020-04190-1. Epub 2020 Nov 6. PMID: 33159215.
Pancreatic metastasis of papillary thyroid carcinoma with an intraductal growth pattern
Endoscopy. 2020 Dec;52(12):E452-E453. doi: 10.1055/a-1164-6157. Epub 2020 May 12. PMID: 32396960.
Factors associated with the risk of patients and healthcare workers to develop COVID-19 during digestive endoscopy in a high-incidence area
Gastrointest Endosc. 2021 Jan;93(1):274-275. doi: 10.1016/j.gie.2020.07.019. PMID: 33353625; PMCID: PMC7833546.
Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy
DEN Open. 2022 Jul 14;3(1):e152. doi: 10.1002/deo2.152. PMID: 35898840; PMCID: PMC9307734.
Efficacy of Endoscopic Ultrasound-Guided Ablation with the HybridTherm Probe in Locally Advanced or Borderline Resectable Pancreatic Cancer: A Phase II Randomized Controlled Trial
Cancers (Basel). 2021 Sep 8;13(18):4512. doi: 10.3390/cancers13184512. PMID: 34572743; PMCID: PMC8464946.
RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of Molecular Features
Cells. 2020 Nov 30;9(12):2561. doi: 10.3390/cells9122561. PMID: 33266052; PMCID: PMC7761443.
Necrosis volume and Choi criteria predict the response to endoscopic ultrasonography-guided HybridTherm ablation of locally advanced pancreatic cancer
Endosc Int Open. 2020 Oct;8(10):E1511-E1519. doi: 10.1055/a-1221-9879. Epub 2020 Oct 7. PMID: 33043122; PMCID: PMC7541180.
Endoscopic ultrasound radiofrequency ablation of pancreatic insulinoma in elderly patients: Three case reports
World J Clin Cases. 2022 Jul 6;10(19):6514-6519. doi: 10.12998/wjcc.v10.i19.6514. PMID: 35979317; PMCID: PMC9294912.
Multicentric Italian survey on daily practice for autoimmune pancreatitis: Clinical data, diagnosis, treatment, and evolution toward pancreatic insufficiency
United European Gastroenterol J. 2020 Jul;8(6):705-715. doi: 10.1177/2050640620924302. Epub 2020 May 12. PMID: 32397913; PMCID: PMC7437084.
EUS-guided ablation with the HybridTherm Probe as second-line treatment in patients with locally advanced pancreatic ductal adenocarcinoma: A case-control study
Endosc Ultrasound. 2022 Oct 5. doi: 10.4103/EUS-D-21-00200. Epub ahead of print. PMID: 36204794.
Routine molecular profiling in both resectable and unresectable pancreatic adenocarcinoma: relevance of cytological samples
Clin Gastroenterol Hepatol. 2022 Oct 21:S1542-3565(22)01003-5. doi: 10.1016/j.cgh.2022.10.014. Epub ahead of print. PMID: 36280101.
EUS-guided ablation with the HybridTherm Probe as second-line treatment in patients with locally advanced pancreatic ductal adenocarcinoma: A case-control study
Endosc Ultrasound. 2022 Sep-Oct;11(5):383-392. doi: 10.4103/EUS-D-21-00200. PMID: 36255026.